Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
NCT00949741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2013-10-22
Summary
The purpose of this study is to define if flow cytometry has more sensitivity for detecting neoplastic cells in cerebrospinal fluid versus conventional cytology.
Conditions
- Diffuse Large Cell Lymphoma
- Lymphoblastic Lymphoma
- Burkitt's Lymphoma
Sponsors & Collaborators
-
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
collaborator OTHER -
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
lead OTHER
Principal Investigators
-
Umberto Vitolo, MD · SCDO Ematologia AOU San Giovanni Battista Torino Italy
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2011-10-31
- Completion
- 2012-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
NCT06781437 ·Status: RECRUITING
-
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
NCT01142674 ·Status: COMPLETED
-
An Italian Experience on Grade 3b Follicular Lymphoma
NCT02927717 ·Status: UNKNOWN
-
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NCT06813573 ·Status: RECRUITING ·Phase: NA
-
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298 ·Status: RECRUITING
-
Clonal Evolution in Follicular Lymphoma
NCT03190928 ·Status: RECRUITING
-
Italian Study of Patients With Lymphoma
NCT06814925 ·Status: RECRUITING
-
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149 ·Status: RECRUITING
-
An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
NCT00097565 ·Status: COMPLETED
-
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
NCT02559583 ·Status: COMPLETED
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study
NCT05162170 ·Status: COMPLETED
-
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
NCT01478269 ·Status: COMPLETED
-
The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study
NCT05169203 ·Status: COMPLETED
-
B-cell Chronic Lymphoid Malignancies Markers
NCT04952974 ·Status: UNKNOWN
-
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT06008691 ·Status: RECRUITING
-
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
NCT05459571 ·Status: COMPLETED ·Phase: PHASE2
-
Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)
NCT04034056 ·Status: COMPLETED
-
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
NCT01369784 ·Status: COMPLETED
-
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
NCT00209209 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas
NCT01153971 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
NCT01250223 ·Status: COMPLETED
-
Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS
NCT02339805 ·Status: COMPLETED ·Phase: NA
-
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
NCT03571997 ·Status: UNKNOWN
-
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma
NCT05058404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3